Miami real estate developer Rishi Kapoor was recently indicted for allegedly orchestrating an $85 million fraud scheme that diverted investor funds into personal luxury purchases. Those purchases reportedly included a 68-foot yacht,
More
The legal industry is experiencing a standout period of growth, with major law firms posting double-digit revenue increases through the first six months of the year. New data from Citi’s law firm
More
Nevada federal judge Gloria Navarro has dismissed a lawsuit against family court judge Mari Parladé, ruling that judicial immunity applies regardless of how a ruling was produced. The plaintiff accused Judge Parladé
More
London’s blue-chip index edged into positive territory on Wednesday, with heavyweight mining shares providing enough momentum to counter a hotter-than-expected domestic inflation reading. The FTSE 100 (LSE:RIO, LSE:AAL, LSE:GLEN, LSE:ANTO) gained 0.06%
More
Lumen Technologies (NYSE: LUMN) has drawn renewed attention from market watchers assessing winners across the telecommunication services sector during the second quarter. The telecoms industry has faced a challenging operating environment, with
More
Wall Street faced renewed pressure as the Nasdaq composite fell sharply, with investors growing increasingly anxious over escalating conflict in the Middle East. Treasury yields remained stubbornly high throughout the session, reflecting
More
London’s FTSE 100 edged higher on Wednesday morning as rising UK inflation, partly driven by energy costs linked to tensions involving Iran, shaped early market sentiment. Inflation in the United Kingdom has
More
Loewe, the German technology firm backed by Kylian Mbappe’s family office, is opening a new retail space at London’s iconic Harrods department store this week. The Brompton Road location represents a significant
More
Valeris, the integrated life sciences commercialization company, has appointed Scott Filosi as its new Chief Commercial Officer, effective immediately. Filosi will take responsibility for leading Valeris’s entire commercial organisation, with a sharp
More
Biokin Pharma’s iza-bren has recorded another significant clinical victory, meeting the primary endpoint of its Panku-Lung01 lung cancer phase 3 trial at an interim analysis. The Chinese drugmaker disclosed the result in
More